Janus Henderson Group
BCYC

Janus Henderson Group’s Bicycle Therapeutics BCYC Stock Holding History

Janus Henderson Group’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-910,930
Closed -$18.3M – 2556
2023
Q3 		$18.3M Sell
910,930
-370,394
-29% -$8.47M 0.01% 551
2023
Q2 		$32.7M Sell
1,281,324
-193,054
-13% -$4.48M 0.02% 479
2023
Q1 		$31.4M Sell
1,474,378
-29,069
-2% -$729K 0.02% 479
2022
Q4 		$44.5M Sell
1,503,447
-1,858,251
-55% -$49.9M 0.03% 395
2022
Q3 		$78.2M Buy
3,361,698
+1,987,209
+145% +$47.3M 0.03% 411
2022
Q2 		$23.1M Sell
1,374,489
-318,285
-19% -$6.71M 0.02% 539
2022
Q1 		$74.3M Sell
1,692,774
-2,635
-0.2% -$123K 0.04% 393
2021
Q4 		$103M Sell
1,695,409
-47,596
-3% -$2.63M 0.04% 351
2021
Q3 		$72.6M Sell
1,743,005
-106,715
-6% -$3.73M 0.03% 446
2021
Q2 		$56.2M Buy
1,849,720
+156,062
+9% +$4.72M 0.02% 540
2021
Q1 		$50.7M Buy
+1,693,658
New +$43.7M 0.02% 547

Other funds holding BCYC

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Janus Henderson Group's BCYC Position: Q4 2023 in Review

Janus Henderson Group sold out of Bicycle Therapeutics (BCYC) in Q4 2023, closing a stake of 910,930 shares — an estimated $18.3M sold.

Janus Henderson Group first reported a position in BCYC in Q1 2021 and held it in 11 quarters. The position peaked at $103M in Q4 2021. 101 funds tracked by Wall St. Rank hold BCYC as of Q4 2023.

  • Janus Henderson Group reported no remaining Bicycle Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Janus Henderson Group sold 910,930 Bicycle Therapeutics shares in Q4 2023, an estimated $18.3M.
  • Janus Henderson Group first reported a position in Bicycle Therapeutics in Q1 2021 and held it in 11 quarters.
  • Janus Henderson Group's Bicycle Therapeutics position peaked at $103M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q4 2023.

Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.